Cepheid (CPHD) Stock Research, Analysis & News

Quick Analysis on Cepheid (CPHD) Stock as of January 28, 2020

The Stock pays no dividend
Average trading volume is relatively low at 0
(See more information about Cepheid (CPHD) Stock below)

Cepheid (CPHD) Stock Profile Summary

Cepheid, a molecular diagnostics company, develops, manufactures, and markets integrated systems for testing in the clinical market, as well as for application in legacy biothreat, industrial, and partner markets. Its systems enable molecular testing for organisms and genetic-based diseases by automation. The company offers SmartCycler system that integrates DNA amplification and detection to allow rapid analysis of a sample; and GeneXpert system that integrates sample preparation in addition to DNA amplification and detection. The GeneXpert system is designed for reference laboratories, hospital central laboratories, and satellite testing locations, such as emergency departments and intensive care units within hospitals and doctors offices. It also provides GeneXpert Infinity System for high volume testing. The company offers tests for the GeneXpert and the SmartCycler systems in the areas of healthcare associated infections, critical infectious disease, genetics, womens health, and oncology. These tests include in vitro diagnostic medical devices, CE marked products, analyte specific reagents, and research use only tests. In the industrial market, it sells its SmartCycler system along with general use polymerase chain reaction reagents and reaction tubes. The company also offers tests for anthrax, pestis, and tullarensis in the biothreat market. Cepheid sells its products through direct sales and distribution channels worldwide. It has strategic commercial relationship with bioMerieux, Inc. for bioMerieux to develop DNA testing products using nucleic acid sequence-based amplification technology. The company was founded in 1996 and is based in Sunnyvale, California.

Cepheid (CPHD) Stock Key Statistics Research and Analysis as of January 28, 2020

Cepheid (CPHD) Stock Competitor Research and Analysis

Abbott Laboratories (ABT)Life Technologies Corporation (LIFE)

Mutual Funds with Cepheid (CPHD) Stock in its top 10 holdings

FundCategoryCPHD Holding Percentage

Stock Research on Cepheid (CPHD)

Latest Market News on Cepheid (CPHD)

Click here to find the latest news on Cepheid (CPHD)

Looking for Market Opportunties?

Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center

See other companies in the same industry

Abbott Laboratories (ABT)
Life Technologies Corporation (LIFE)